nelfinavir has been researched along with Sensitivity and Specificity in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 17 (80.95) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, H; Mimoto, T; Nojima, S; Shintani, M; Takaku, H; Terashima, K | 1 |
| Boesmans, D; Di Fazio, V; Elens, L; Haufroid, V; Vanbinst, R; Veriter, S; Wallemacq, P | 1 |
| Burgers, PC; Dekker, LJ; Gruters, RA; Luider, TM; Osterhaus, AD; Reedijk, ML; van Kampen, JJ | 1 |
| Ahmed, I; Bégaud, B; Tubert-Bitter, P | 1 |
| Brundage, RC; Douglas, SD; Fletcher, CV; Flynn, PM; Kline, MW; Spector, SA; Starr, SE; Yong, FH | 1 |
| Aulagner, G; Bleyzac, N; Bourhis, Y; Coudray, S; Favetta, P; Gagneu, MC; Janoly, A; Oger, I | 1 |
| Chan, KK; Fan-Havard, P; Hua, Y | 1 |
| Afonso, AO; Costa, AJ; Cunha, SM; Lambert, JS; Machado, ES; Oliveira, RH; Sill, AM; Soares, MA; Tanuri, A | 1 |
| Hou, Z; Jing, Q; Ren, F; Shen, Y; Tang, Y; Yu, X | 1 |
| Fuse, T; Kitazato, K; Kobayashi, N; Watanabe, K | 1 |
| de Hoon, J; Van Wijngaerden, E; Verbesselt, R | 1 |
| Choi, SO; Kashuba, AD; Rezk, NL | 1 |
| Back, DJ; Cane, P; Chandler, B; Detsika, MG; Khoo, SH; Owen, A; Winstanley, C | 1 |
| Bastiani, E; Donadel, E; Genco, F; Maserati, R; Meroni, V; Rinaldi, S; Uglietti, A | 1 |
| Collins, M; Detmer, J; Fultz, T; Hamren, S; Kern, D; Peterkin, JJ; Sheridan, P; Todd, J; Urdea, M; White, R; Yeghiazarian, T | 1 |
| Daniels, VL; Khalil, DA; Naret, DG; Shetty, BV; Wilkinson, JM; Williams, LJ; Wu, EY | 1 |
| Farinotti, R; Lamotte, C; Peytavin, G | 1 |
| Blanco, JL; Carné, X; Gatell, JM; López-Púa, Y; Mallolas, J; Sarasa-Nacenta, M | 1 |
| Bartoli, A; Feroggio, M; Gianelli, L; Maserati, R; Montagna, M; Regazzi, MB; Villani, P | 1 |
| Bourin, M; Dailly, E; Jolliet, P; Kergueris, MF; Thomas, L | 1 |
| Aweeka, FT; Blaschke, TF; Fang, F; Herforth, C; Jayewardene, AL; Motoya, T; Stone, JA | 1 |
2 trial(s) available for nelfinavir and Sensitivity and Specificity
| Article | Year |
|---|---|
Efavirenz liquid formulation in human immunodeficiency virus-infected children.
Topics: Administration, Oral; Alkynes; Benzoxazines; Child; Child, Preschool; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Nelfinavir; Oxazines; RNA, Viral; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; Survival Analysis; Treatment Outcome; Viral Load | 2002 |
High-performance liquid chromatographic method for the determination of nelfinavir, a novel HIV-1 protease inhibitor, in human plasma.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Drug Stability; HIV Protease Inhibitors; Humans; Isoquinolines; Nelfinavir; Reproducibility of Results; Sensitivity and Specificity; Sulfonic Acids | 1997 |
19 other study(ies) available for nelfinavir and Sensitivity and Specificity
| Article | Year |
|---|---|
Structure-activity relationships of novel HIV-1 protease inhibitors containing the 3-amino-2-chlorobenzoyl-allophenylnorstatine structure.
Topics: Animals; Dogs; Drug Design; Hepatocytes; HIV Protease Inhibitors; HIV-1; Humans; Molecular Structure; Mutation; Phenylbutyrates; Sensitivity and Specificity; Structure-Activity Relationship | 2008 |
Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.
Topics: Alkynes; Atazanavir Sulfate; Benzoxazines; Carbamates; Chromatography, High Pressure Liquid; Cyclopropanes; Furans; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Nelfinavir; Nevirapine; Oligopeptides; Pyridines; Pyrimidinones; Pyrones; Reproducibility of Results; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sensitivity and Specificity; Solid Phase Extraction; Sulfonamides | 2009 |
A mass spectrometry based imaging method developed for the intracellular detection of HIV protease inhibitors.
Topics: Cell Line; Cyclotrons; Equipment Design; HIV Protease Inhibitors; Image Enhancement; Mass Spectrometry; Nelfinavir; Saquinavir; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectroscopy, Fourier Transform Infrared; Time Factors | 2009 |
Comparison of two drug safety signals in a pharmacovigilance data mining framework.
Topics: Anti-HIV Agents; Bayes Theorem; Data Mining; Databases, Factual; France; Humans; Myocardial Infarction; Nelfinavir; Pharmacovigilance; ROC Curve; Saquinavir; Sensitivity and Specificity | 2016 |
Simple and rapid high-performance liquid chromatographic method for nelfinavir, M8 nelfinavir metabolite, ritonavir and saquinavir assay in plasma.
Topics: Chromatography, High Pressure Liquid; HIV Protease Inhibitors; Humans; Nelfinavir; Reference Standards; Ritonavir; Saquinavir; Sensitivity and Specificity | 2002 |
Subnanogram on-line column-switching liquid chromatographic-tandem mass spectrometric quantification method for nelfinavir and methoxyphenol metabolite M1 in rat plasma.
Topics: Animals; Chromatography, High Pressure Liquid; Female; HIV Protease Inhibitors; Mass Spectrometry; Nanotechnology; Nelfinavir; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity | 2004 |
Alternative, age- and viral load-related routes of nelfinavir resistance in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.
Topics: Age Factors; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Cohort Studies; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Male; Microbial Sensitivity Tests; Mutation; Nelfinavir; Pharmacogenetics; Risk Factors; Sampling Studies; Sensitivity and Specificity; Viral Load | 2004 |
Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLC.
Topics: Chromatography, High Pressure Liquid; Drug Stability; HIV Protease Inhibitors; Nelfinavir; Pharmaceutical Preparations; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2006 |
Establishment of a new cell line inducibly expressing HIV-1 protease for performing safe and highly sensitive screening of HIV protease inhibitors.
Topics: Cell Line; Doxycycline; Drug Evaluation, Preclinical; Gene Expression Regulation; Green Fluorescent Proteins; HIV Protease; HIV Protease Inhibitors; Humans; Nelfinavir; Recombinant Fusion Proteins; Saquinavir; Sensitivity and Specificity | 2006 |
Simultaneous determination of 8 HIV protease inhibitors in human plasma by isocratic high-performance liquid chromatography with combined use of UV and fluorescence detection: amprenavir, indinavir, atazanavir, ritonavir, lopinavir, saquinavir, nelfinavir
Topics: Atazanavir Sulfate; Calibration; Carbamates; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Fluorescence; Furans; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Nelfinavir; Oligopeptides; Pyridines; Pyrimidinones; Reproducibility of Results; Ritonavir; Saquinavir; Sensitivity and Specificity; Sulfonamides; Ultraviolet Rays | 2007 |
High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.
Topics: Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Carbamates; Chromatography, High Pressure Liquid; Cyclopropanes; Drug Stability; Furans; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Molecular Structure; Nelfinavir; Nevirapine; Oligopeptides; Oxazines; Pyridines; Pyrimidinones; Pyrones; Reproducibility of Results; Ritonavir; Saquinavir; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Sulfonamides; Time Factors | 2007 |
Detection and quantification of minority HIV isolates harbouring the D30N mutation by real-time PCR amplification.
Topics: Amino Acid Substitution; Drug Resistance, Viral; HIV; HIV Infections; Humans; Mutation; Nelfinavir; Polymerase Chain Reaction; Sensitivity and Specificity | 2007 |
Evaluation of Elisa test for therapeutic monitoring of Nelfinavir in HIV-positive patients.
Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Drug Monitoring; Enzyme-Linked Immunosorbent Assay; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Nelfinavir; Reagent Kits, Diagnostic; Sensitivity and Specificity | 2007 |
An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma.
Topics: Anti-HIV Agents; Base Sequence; DNA Probes; Evaluation Studies as Topic; Genetic Variation; Genotype; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Isoquinolines; Molecular Probe Techniques; Molecular Sequence Data; Nelfinavir; Nucleic Acid Amplification Techniques; Reproducibility of Results; RNA, Viral; Sensitivity and Specificity; Sulfonic Acids; Virology | 1996 |
Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; HIV Protease Inhibitors; Humans; Nelfinavir; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1999 |
Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography.
Topics: Carbamates; Chromatography, High Pressure Liquid; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Nelfinavir; Reference Standards; Reproducibility of Results; Ritonavir; Saquinavir; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Sulfonamides | 2001 |
Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assay.
Topics: Alkynes; Benzoxazines; Carbamates; Chromatography, Liquid; Cyclopropanes; Delavirdine; Drug Monitoring; Furans; HIV Protease Inhibitors; Humans; Indinavir; Mass Spectrometry; Nelfinavir; Nevirapine; Oxazines; Reproducibility of Results; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sensitivity and Specificity; Sulfonamides | 2001 |
High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid e
Topics: Calibration; Carbamates; Chromatography, High Pressure Liquid; Furans; HIV Protease Inhibitors; Humans; Indinavir; Nelfinavir; Nevirapine; Reference Standards; Reproducibility of Results; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sensitivity and Specificity; Sulfonamides | 2001 |
Determination of nelfinavir free drug concentrations in plasma by equilibrium dialysis and liquid chromatography/tandem mass spectrometry: important factors for method optimization.
Topics: Adsorption; Calibration; Chemical Phenomena; Chemistry, Physical; Chromatography, Liquid; Dialysis; HIV Protease Inhibitors; Humans; Hydrogen-Ion Concentration; Mass Spectrometry; Molecular Structure; Nelfinavir; Protein Binding; Reproducibility of Results; Sensitivity and Specificity | 2002 |